DBV TECHNOLOGIES SA (DBV.DE) Fundamental Analysis & Valuation

FRA:DBV • FR0010417345

Current stock price

3.618 EUR
+0.14 (+4.12%)
Last:

This DBV.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DBV.DE Profitability Analysis

1.1 Basic Checks

  • In the past year DBV has reported negative net income.
  • In the past year DBV has reported a negative cash flow from operations.
  • DBV had negative earnings in each of the past 5 years.
  • DBV had a negative operating cash flow in each of the past 5 years.
DBV.DE Yearly Net Income VS EBIT VS OCF VS FCFDBV.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • With a Return On Assets value of -85.56%, DBV is not doing good in the industry: 73.42% of the companies in the same industry are doing better.
  • The Return On Equity of DBV (-142.22%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -85.56%
ROE -142.22%
ROIC N/A
ROA(3y)-84.27%
ROA(5y)-75.7%
ROE(3y)-172.64%
ROE(5y)-138.93%
ROIC(3y)N/A
ROIC(5y)N/A
DBV.DE Yearly ROA, ROE, ROICDBV.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 91.34%, DBV belongs to the top of the industry, outperforming 82.28% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DBV has declined.
  • DBV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-2.02%
DBV.DE Yearly Profit, Operating, Gross MarginsDBV.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DBV.DE Health Analysis

2.1 Basic Checks

  • DBV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DBV has more shares outstanding than it did 1 year ago.
  • DBV has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DBV has a worse debt to assets ratio.
DBV.DE Yearly Shares OutstandingDBV.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DBV.DE Yearly Total Debt VS Total AssetsDBV.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 8.84 indicates that DBV is not in any danger for bankruptcy at the moment.
  • DBV's Altman-Z score of 8.84 is amongst the best of the industry. DBV outperforms 84.81% of its industry peers.
  • DBV has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of DBV (0.08) is better than 67.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 8.84
ROIC/WACCN/A
WACC8.01%
DBV.DE Yearly LT Debt VS Equity VS FCFDBV.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • DBV has a Current Ratio of 2.45. This indicates that DBV is financially healthy and has no problem in meeting its short term obligations.
  • DBV has a Current ratio (2.45) which is comparable to the rest of the industry.
  • DBV has a Quick Ratio of 2.45. This indicates that DBV is financially healthy and has no problem in meeting its short term obligations.
  • DBV has a Quick ratio (2.45) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.45
DBV.DE Yearly Current Assets VS Current LiabilitesDBV.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DBV.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.66% over the past year.
  • The Revenue has grown by 224.69% in the past year. This is a very strong growth!
  • The Revenue has been growing slightly by 0.50% on average over the past years.
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)224.69%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%-59.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.84% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 75.93% on average over the next years. This is a very strong growth
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y21.57%
Revenue Next 5Y75.93%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DBV.DE Yearly Revenue VS EstimatesDBV.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
DBV.DE Yearly EPS VS EstimatesDBV.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. DBV.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DBV. In the last year negative earnings were reported.
  • Also next year DBV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DBV.DE Price Earnings VS Forward Price EarningsDBV.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DBV.DE Per share dataDBV.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.4%
EPS Next 3Y10.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DBV.DE Dividend Analysis

5.1 Amount

  • No dividends for DBV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DBV.DE Fundamentals: All Metrics, Ratios and Statistics

DBV TECHNOLOGIES SA

FRA:DBV (4/8/2026, 7:00:00 PM)

3.618

+0.14 (+4.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-26
Earnings (Next)07-27
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap1.01B
Revenue(TTM)15.73M
Net Income(TTM)-122.55M
Analysts80
Price Target5.99 (65.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)48.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-91.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 309.67
P/FCF N/A
P/OCF N/A
P/B 13.66
P/tB 13.66
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.01
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -85.56%
ROE -142.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.34%
FCFM N/A
ROA(3y)-84.27%
ROA(5y)-75.7%
ROE(3y)-172.64%
ROE(5y)-138.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-2.02%
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.61%
Cap/Sales 8.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 2.45
Altman-Z 8.84
F-Score2
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)25.42%
Cap/Sales(5y)23.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue 1Y (TTM)224.69%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%-59.25%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y21.57%
Revenue Next 5Y75.93%
EBIT growth 1Y-31.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-23.2%
EBIT Next 3Y27.74%
EBIT Next 5YN/A
FCF growth 1Y0.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.02%
OCF growth 3YN/A
OCF growth 5YN/A

DBV TECHNOLOGIES SA / DBV.DE Fundamental Analysis FAQ

What is the fundamental rating for DBV stock?

ChartMill assigns a fundamental rating of 3 / 10 to DBV.DE.


What is the valuation status for DBV stock?

ChartMill assigns a valuation rating of 0 / 10 to DBV TECHNOLOGIES SA (DBV.DE). This can be considered as Overvalued.


How profitable is DBV TECHNOLOGIES SA (DBV.DE) stock?

DBV TECHNOLOGIES SA (DBV.DE) has a profitability rating of 1 / 10.